CardiaTec Biosciences: Funding, Investors & Team (Oct 2026)
CardiaTec is a computerized biotechnology adventure consolidating the force of AI and master ability to overhaul cardiovascular medication revelation.
CardiaTec Biosciences has raised $8.2M across 2 funding rounds on record, the most recent a Seed of $6.5M announced in Sep 2024.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
CardiaTec Biosciences Company Profile and Key Stats
Latest funding round on record: Sep 2024.
CardiaTec Biosciences Funding Rounds
CardiaTec Biosciences raised $1.7M in a Pre-Seed announced in Jul 2022.
2.2 years later, a Seed of $6.5M was announced in Sep 2024.
CardiaTec Biosciences Founders and Leadership Team
Contact details for the CardiaTec Biosciences team: 2 of 2 have an email address on file.
Start 14-day free trial →CardiaTec Biosciences Funding Compared to Other Biotechnology Startups
CardiaTec Biosciences' latest round of $6.5M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CardiaTec Biosciences in Biotechnology and Cambridge
Companies Similar to CardiaTec Biosciences
Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…
OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…
HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…
R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…
The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…
Argonaute RNA company research projects build on existing intellectual property.
An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…
ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
CardiaTec Biosciences Funding FAQs
What does CardiaTec Biosciences do?
CardiaTec is a computerized biotechnology adventure consolidating the force of AI and master ability to overhaul cardiovascular medication revelation.
How much funding has CardiaTec Biosciences raised?
CardiaTec Biosciences has raised $8.2M across 2 rounds on record. The most recent is a Seed of $6.5M announced in Sep 2024.
When did CardiaTec Biosciences last raise funding?
CardiaTec Biosciences' most recent funding round on record is a Seed of $6.5M, announced in Sep 2024.
Who founded CardiaTec Biosciences?
FundedIQ lists Namshik Han (Founder) at CardiaTec Biosciences.
Who is the CEO of CardiaTec Biosciences?
Raphael Peralta is listed as CEO at CardiaTec Biosciences.
Where is CardiaTec Biosciences headquartered?
CardiaTec Biosciences is based in Cambridge, Cambridgeshire, United Kingdom.
How many employees does CardiaTec Biosciences have?
CardiaTec Biosciences is in the 1-10 employee band.
How does CardiaTec Biosciences' funding compare to other Biotechnology startups?
CardiaTec Biosciences' latest round of $6.5M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's CardiaTec Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CardiaTec Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.